Muhammad Ali Fikry
University of Tsukuba, Japan
Posters & Accepted Abstracts: J Cancer Sci Ther
Glycoprotein NMB (GPNMB) is a type I transmembrane protein, which is profoundly expressed in many
malignant tumor cells and it is considered to be one of the poor prognostic factors. Previously, we showed that
GPNMB confers the tumorigenic potential, such as sphere formation in vitro and xenograft tumor formation in
vivo, to non-tumorigenic mammary gland epithelial cells. Additionally, we showed that GPNMB induced epithelialmesenchymal
transition (EMT) and proved to be involved in cell migratory and invasive ability of breast cancer cells.
Furthermore, we demonstrated that GPNMB surface expression enhanced in spheres and in vivo tumors of breast
cancer cells and induced stem-like properties including the high expression of stem-related genes, sphere-forming
ability and tumor growth. These GPNMB functions depend on the tyrosine phosphorylation in the intracellular
domain of GPNMB, which is known as hemi-immuno receptor tyrosine-based activation motif (ITAM). In this
study, we would like to clarify the mechanism of how GPNMB plays a role in cancer progression in different types
of cancers. We established GPNMB wild-type or mutant stably expressing cell lines and reviewed the effects on cell
migration and invasiveness in vitro and in vivo. When we examined the expression of GPNMB in invasive cancer
cells, we found that GPNMB was secreted in the culture medium. The exact mechanism of how GPNMB promote
invasiveness remains unclear, tyrosine phosphorylation and shedding/secretion of its protein might correlate with
this mechanism. Further experiments must be conducted by focusing on those possible clues that might lead us to
a definite conclusion.
Recent Publications
1. Okita, et al. (2017) The transcription factor MAFK induces EMT and malignant progression of triple-negative
breast cancer through its target GPNMB. Sci. Signal. 10:474.
2. Chen C, et al. (2018) Glycoprotein nmb is exposed on the surface of dormant breast cancer cells and induces
stem cell-like properties. Cancer Res. 78(22):6424-6435.
Muhammad Ali Fikry has completed his Bachelor’s degree in Biology at Gadjah Mada University, Indonesia. Currently, he is pursuing his Master’s degree in Medical Sciences program at the University of Tsukuba, Japan. He works at the Laboratory of Experimental Pathology and focusing his research on the investigation of GPNMB role in cancer progression.
E-mail: S1726083@s.tsukuba.ac.jp
Cancer Science & Therapy received 3968 citations as per Google Scholar report